Reply To: How can developers demonstrate comparability of iPSC lines and derived therapeutic products? · · Home › Forums › General Discussion › General Discussion › How can developers demonstrate comparability of iPSC lines and derived therapeutic products? › Reply To: How can developers demonstrate comparability of iPSC lines and derived therapeutic products? 24th July 2018 at 9:48 am #964 Stephen SullivanKeymaster Michael May et al. discussing cell characterisation and comparability and the role of regulation:
